PATENT CLAIM ANALYSIS

Application Number: 15927007
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "093210"]

Abstract:
A genetic method to kill cancer by suffocation is presented. The invention involves directly administering a bacterial plasmid in the form of an expression vector to cancer cells or tissue in a patient with cancerous growth. The plasmid is in the form of an expression vector with a nucleic acid encoding the silk protein gene.

Claim (Index 11):
A method to treat solid cancer cells such as breast, prostate, liver, renal, lung, pancreatic, ovarian, cervical, thyroid, melanoma, and sarcoma using a plasmid comprising:\n selecting a patient with breast, prostate, liver, renal, lung, pancreatic, ovarian, cervical, thyroid, melanoma, or sarcoma cancer cells; and administering a therapeutic dose of a plasmid in the form of an expression vector to said patient, wherein the plasmid comprises a nucleic acid encoding the silk protein gene.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.48718
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10550280', '11932944', '11932997', '10159946', '10503642']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7015822655120826
- 35 USC 102 Novelty (BERT): 0.4869268427241891
- Combined Prediction Score: 0.6801167232332932
- Mean Citation Score: 180.610554
- Max Citation Score: 192.469
- Similarity Product: 136.73838378328085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test